IMIGRAPE
MRP: 531
Packaging: 10 x 10
Pack Type: tablet
Composition:
Imiglimin 500 IR
Indication:
used to manage type 2 diabetes. It contains Imiglimin, a dual-action drug that works by improving insulin sensitivity and enhancing insulin secretion. This combination helps in regulating blood sugar levels, promoting better glucose control. It is generally prescribed when lifestyle changes and other diabetes medications are insufficient. It’s particularly beneficial for adults with type 2 diabetes to help manage their condition more effectively.
Description:
Imiglimin 500mg IR (Immediate Release) is an innovative oral antidiabetic medication used to manage type 2 diabetes mellitus. Imiglimin works by improving mitochondrial function, which enhances insulin sensitivity in muscle and liver tissues, and helps regulate insulin secretion from pancreatic beta cells. This unique mechanism supports better blood glucose control with potentially fewer side effects compared to traditional therapies.
The immediate-release formulation ensures quick absorption for effective glycemic management throughout the day.
Tags:
- Improves insulin sensitivity and secretion
- Unique mitochondrial mechanism of action
- Supports better blood sugar control
- Immediate-release for quick action
- May have fewer side effects
Usage Information
Dosage
Take as prescribed, usually once or twice daily. Take with or without food. Follow your healthcare provider’s directions.
Side Effects
Common side effects: Mild gastrointestinal discomfort Headache Dizziness Rare side effects: Hypoglycemia (especially if combined with other antidiabetics) Allergic reactions (rare)
Contraindications
Type 1 diabetes Diabetic ketoacidosis Known hypersensitivity to Imiglimin Severe renal or hepatic impairment Pregnancy and breastfeeding (consult doctor)